Skip to content
10-K

Annual Report

Hepion Pharmaceuticals, Inc. CTRVP HEPA

0001493152-26-009755

← back to feed
Filed
Mar 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 11, 2026 11.62M sh
Shares Diluted FY 2025 · Dec 31, 2025 9.41M sh
Shares Diluted FY 2025 · Dec 31, 2024 122.89K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$3.27M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$18.22M
Stockholders Equity FY 2025 · Dec 31, 2025 $2.67M
Stockholders Equity FY 2025 · Dec 31, 2024 −$1.86M
Stockholders Equity FY 2025 · Dec 31, 2023 $7.28M
Current Liabilities FY 2025 · Dec 31, 2025 $299.38K
Current Liabilities FY 2025 · Dec 31, 2024 $3.14M
Total Liabilities FY 2025 · Dec 31, 2025 $402.41K
Total Liabilities FY 2025 · Dec 31, 2024 $3.48M
Current Assets FY 2025 · Dec 31, 2025 $3.07M
Current Assets FY 2025 · Dec 31, 2024 $1.61M
Total Assets FY 2025 · Dec 31, 2025 $3.07M
Total Assets FY 2025 · Dec 31, 2024 $1.61M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.88
Eps Diluted FY 2025 · Dec 31, 2024 −$107.35
Eps Basic FY 2025 · Dec 31, 2025 −$0.88
Eps Basic FY 2025 · Dec 31, 2024 −$107.35
Sga Expense FY 2025 · Dec 31, 2025 $3.32M
Sga Expense FY 2025 · Dec 31, 2024 $7.5M
Rd Expense FY 2025 · Dec 31, 2025 $445.51K
Rd Expense FY 2025 · Dec 31, 2024 $11.85M
Net Income FY 2025 · Dec 31, 2025 −$8.28M
Net Income FY 2025 · Dec 31, 2024 −$13.19M
Operating Income FY 2025 · Dec 31, 2025 −$4.16M
Operating Income FY 2025 · Dec 31, 2024 −$19.35M